Peran Apoteker Dalam Peningkatan Mutu dan Keselamatan

Pasien Untuk Meningkatkan Produktivitas dan Efisiensi

Rumah Sakit

Dra. Yulia Trisna, Apt., M.Pharm

 Rumah Sakit :
Quality, Safety, Cost
 Kemajuan teknologi
VS
Keterbatasan sumber daya

Kemajuan teknologi
Biaya

„health
gap“

Sumber daya

Waktu
 MUTU

KEAMANAN OBAT KHASIAT

BIAYA
 Pemilihan Obat

AFFORDABILITY
COST
SAFETY
EFFECTIVENESS
EFFICACY
QUALITY
 What Hospital Pharmacists Do

Courtesy of European Association of Hospital Pharmacists

PENGELOLAAN OBAT
 PEMANFAATAN TEKNOLOGI INFORMASI

ELECTRONIC PRESCRIBING:

• Meningkatkan keselamatan pasien

• Mempercepat pelayanan
• Mempercepat proses tagihan
AUTOMASI PENYIAPAN OBAT
Automated Dispensing Cabinet
PRODUKSI DAN ASEPTIC DISPENSING
Robotic I.V. Admixture
 FARMASI KLINIK

Wawancara Pelayanan
Riwayat Penggunaan Obat Informasi Obat Pengkajian Resep

Monitoring Terapi Obat Visite Konseling Obat

 Peran Farmasi RS meningkatkan keselamatan pasien

Admission medication history

Allergy check
Prescribing protocols
Formulary
Medication review
Drug distribution system

Administration instructions

Drug therapy monitoring

•Adapted by P.Thornton from J. Reason, 9/01

 Manfaat Ekonomi Pelayanan Farmasi Klinik

Pharmacotherapy 2014; 34(8): 771-793

 Dampak Ekonomi dari Pelayanan Farmasi Klinik
 Chisholm-Burns MA, Zivin JSG, Lee JK, et al. Economic effects of pharmacists on
health outcomes in the United States: A systematic review. Am J Health-Syst Pharm,
2010; 67:1624-34
 MacLaren R, Bond CA, Martin SJ, Fike D. Clinical and economic outcomes of
involving pharmacists in the direct care of critically ill patients with infections. Crit
Care Med 2008;36:3184–9.
 Kopp BJ, Mrsan M, Erstad BL, Duby JJ. Cost implications of and potential adverse
events prevented by interventions of a critical care pharmacist. Am J Health Syst
Pharm 2007;64:2483–7.
 Zaidi ST, Hassan Y, Postma MJ, Ng SH. Impact of pharmacist recommendations on
the cost of drug therapy in ICU patients at a Malaysian hospital. Pharm World Sci
2003;25:299–302.
 Gandhi PJ, Smith BS, Tataronis GR, et al. Impact of a pharmacist on drug costs in
a coronary care unit. Am J Health Syst Pharm 2001;58:497–503.
 Non-value
added/waste

Value
added
Sebelum Lean
Setelah Lean
(Am J Health-Syst Pharm. 2017;73: 958-61)
TERIMA KASIH